Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Jun-23 4:07 PM View:  | Esperion Therapeutics, Inc. (ESPR) | 15-Jun-23 | Grant | 5,150 | -- | -- | 16% 31.77K to 36.92K | |
| 07-Feb-22 4:14 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 04-Feb-22 | Grant | 2,750 | -- | -- | 74% 3.69K to 6.44K | |
| 28-May-21 4:17 PM View: | Esperion Therapeutics, Inc. (ESPR) | 27-May-21 | Grant | 12,376 | -- | -- | 64% 19.39K to 31.77K | |
| 16-Mar-21 4:58 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 16-Mar-21 | Acquisition (other) | 2,717 | -- | -- | 14% 18.78K to 21.5K | |
| 16-Mar-21 4:58 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 16-Mar-21 | Disposition (other) | 17,804 | -- | -- | (83%) 21.5K to 3.69K | |
| 16-Mar-21 4:58 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 15-Mar-21 | Market Sale | 4,250 | $15.87 | $67,447.50 | (18%) 23.03K to 18.78K | |
| 16-Mar-21 4:58 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 12-Mar-21 | Acquisition (other) | 6,192 | -- | -- | < 1% 636.06K to 642.25K | |
| 16-Mar-21 4:58 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 12-Mar-21 | Disposition (other) | 619,221 | -- | -- | (96%) 642.25K to 23.03K | |
| 29-May-20 4:38 PM View: | Esperion Therapeutics, Inc. (ESPR) | 28-May-20 | Grant | 6,106 | -- | -- | 46% 13.29K to 19.39K | |
| 29-Jan-20 5:30 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 28-Jan-20 | Disposition | 36,431 | $6.30 | $229,515.00 | (1%) 3.45M to 3.42M | |
| 29-Jan-20 5:30 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 28-Jan-20 | Disposition | 3,418,540 | $6.30 | $21,536,800.00 | (100%) 3.42M to 0 | |
| 31-May-19 6:09 PM View: | Esperion Therapeutics, Inc. (ESPR) | 29-May-19 | Grant | 4,967 | -- | -- | 60% 8.32K to 13.29K | |
| 21-Mar-19 9:02 AM View: | Esperion Therapeutics, Inc. (ESPR) | 21-Mar-19 | Acquisition (other) | 1,356 | -- | -- | 5% 24.75K to 26.11K | |
| 21-Mar-19 9:02 AM View: | Esperion Therapeutics, Inc. (ESPR) | 21-Mar-19 | Disposition (other) | 17,790 | -- | -- | (68%) 26.11K to 8.32K | |
| 21-Mar-19 9:02 AM View: | Esperion Therapeutics, Inc. (ESPR) | 19-Mar-19 | Acquisition (other) | 17,790 | -- | -- | 2% 1.12M to 1.14M | |
| 21-Mar-19 9:02 AM View: | Esperion Therapeutics, Inc. (ESPR) | 19-Mar-19 | Disposition (other) | 1,101,080 | -- | -- | (96%) 1.14M to 40.08K | |
| 21-Mar-19 9:02 AM View: | Esperion Therapeutics, Inc. (ESPR) | 19-Mar-19 | Market Sale | 15,329 | $44.73 | $685,596.00 | (38%) 40.08K to 24.75K | 37% |
| 26-Jun-18 5:06 PM View: | Esperion Therapeutics, Inc. (ESPR) | 22-Jun-18 | Acquisition (other) | 3,846 | -- | -- | < 1% 1.14M to 1.14M | |
| 26-Jun-18 5:06 PM View: | Esperion Therapeutics, Inc. (ESPR) | 22-Jun-18 | Disposition (other) | 21,471 | -- | -- | (2%) 1.14M to 1.12M | |
| 04-Jun-18 4:20 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 31-May-18 | Acquisition (other) | 5,000 | -- | -- | < 1% 3.47M to 3.48M | |
| 04-Jun-18 4:20 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 31-May-18 | Disposition (other) | 25,000 | -- | -- | (< 1%) 3.48M to 3.45M | |
| 26-Jan-18 5:24 PM View: | Esperion Therapeutics, Inc. (ESPR) | 26-Jan-18 | Acquisition (other) | 645 | -- | -- | < 1% 1.15M to 1.15M | |
| 26-Jan-18 5:24 PM View: | Esperion Therapeutics, Inc. (ESPR) | 26-Jan-18 | Disposition (other) | 8,500 | -- | -- | (< 1%) 1.15M to 1.14M | |
| 26-Jan-18 5:24 PM View: | Esperion Therapeutics, Inc. (ESPR) | 25-Jan-18 | Market Option Sale | 11,674 | $71.79 | $838,076.00 | (1%) 1.16M to 1.15M | 61% |
| 26-Jan-18 5:24 PM View: | Esperion Therapeutics, Inc. (ESPR) | 24-Jan-18 | Payment of Exercise | 6,931 | $71.82 | $497,784.00 | (< 1%) 2.02M to 2.01M | 61% |
| 26-Jan-18 5:24 PM View: | Esperion Therapeutics, Inc. (ESPR) | 24-Jan-18 | Acquisition (other) | 8,500 | -- | -- | < 1% 1.94M to 1.95M | |
| 26-Jan-18 5:24 PM View: | Esperion Therapeutics, Inc. (ESPR) | 24-Jan-18 | Disposition (other) | 850,000 | -- | -- | (42%) 2.01M to 1.16M | |
| 26-Jan-18 5:24 PM View: | Esperion Therapeutics, Inc. (ESPR) | 24-Jan-18 | Option Exercise | 71,235 | $6.99 | $497,933.00 | 4% 1.95M to 2.02M | |
| 24-Jan-18 4:09 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 22-Jan-18 | Acquisition (other) | 2,250 | -- | -- | < 1% 2.54M to 2.55M | |
| 24-Jan-18 4:09 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 22-Jan-18 | Disposition (other) | 2,250 | -- | -- | (< 1%) 2.55M to 2.54M | |
| 08-Dec-17 4:14 PM View: | Esperion Therapeutics, Inc. (ESPR) | 08-Dec-17 | Acquisition (other) | 2,472 | -- | -- | < 1% 1.97M to 1.97M | |
| 08-Dec-17 4:14 PM View: | Esperion Therapeutics, Inc. (ESPR) | 08-Dec-17 | Disposition (other) | 32,560 | -- | -- | (2%) 1.97M to 1.94M | |
| 08-Dec-17 4:14 PM View: | Esperion Therapeutics, Inc. (ESPR) | 06-Dec-17 | Acquisition (other) | 3,291 | -- | -- | < 1% 2.3M to 2.31M | |
| 08-Dec-17 4:14 PM View: | Esperion Therapeutics, Inc. (ESPR) | 06-Dec-17 | Disposition (other) | 329,083 | -- | -- | (14%) 2.31M to 1.98M | |
| 08-Dec-17 4:14 PM View: | Esperion Therapeutics, Inc. (ESPR) | 06-Dec-17 | Market Sale | 9,326 | $53.85 | $502,205.00 | (< 1%) 1.98M to 1.97M | 48% |
| 11-Sep-17 5:25 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 11-Sep-17 | Acquisition (other) | 1,650 | -- | -- | < 1% 2.54M to 2.55M | |
| 11-Sep-17 5:25 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 11-Sep-17 | Disposition (other) | 1,650 | -- | -- | (< 1%) 2.55M to 2.54M | |
| 14-Aug-17 4:47 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 10-Aug-17 | Payment of Exercise | 1,727,680 | $5.06 | $8,742,060.00 | (33%) 5.2M to 3.47M | |
| 14-Aug-17 4:47 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 10-Aug-17 | Option Exercise | 2,811,240 | $3.11 | $8,750,000.00 | 118% 2.39M to 5.2M | |
| 19-Jan-17 4:42 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 17-Jan-17 | Grant | 4,500 | -- | -- | < 1% 2.54M to 2.54M | |
| 05-Aug-16 5:00 PM View: | Marinus Pharmaceuticals, Inc. (MRNS) | 03-Aug-16 | Grant | 3,300 | -- | -- | < 1% 2.54M to 2.54M | |
| 12-Jul-16 4:32 PM View: | Celator Pharmaceuticals Inc (NONE) | 12-Jul-16 | Disposition | 2,401,520 | $30.25 | $72,646,096.00 | (100%) 2.4M to 0 | |
| 12-Nov-15 4:54 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 11-Nov-15 | Market Sale | 50,000 | $10.31 | $515,500.00 | (2%) 2.44M to 2.39M | 77% |
| 12-Nov-15 4:54 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 10-Nov-15 | Market Sale | 179,074 | $10.43 | $1,867,740.00 | (7%) 2.62M to 2.44M | 77% |
| 12-Nov-15 4:54 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 09-Nov-15 | Market Sale | 320,926 | $10.01 | $3,212,470.00 | (11%) 2.94M to 2.62M | 76% |
| 29-Sep-15 5:21 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 25-Sep-15 | Market Sale | 9,310 | $8.22 | $76,528.20 | (< 1%) 2.95M to 2.94M | 71% |
| 18-Aug-15 6:07 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 18-Aug-15 | Acquisition (other) | 31,431 | -- | -- | 6% 529.84K to 561.27K | |
| 18-Aug-15 6:07 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 18-Aug-15 | Disposition (other) | 483,521 | -- | -- | (86%) 561.27K to 77.75K | |
| 18-Aug-15 6:07 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 14-Aug-15 | Market Sale | 37,843 | $7.51 | $284,201.00 | (7%) 567.68K to 529.84K | 68% |
| 22-May-15 5:11 PM View: | Achillion Pharmaceuticals, ... (ACHN) | 21-May-15 | Acquisition (other) | 222,630 | -- | -- | 5% 4.92M to 5.14M |